Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.

Inclusion Criteria:

Adults aged over 18 years with the evidence of alcoholic liver disease (ALD) based on a thorough history, physical examination, and laboratory tests and all of the following:

• Chronic alcohol intake, Identified with AUDIT(Alcohol Use Disorder Inventory Test) Questionnaire
• Active alcohol use until 4 weeks prior to presentation
• ALT and AST elevated >1.5 times the upper limit of normal
• Over 1.5 ratio of AST to ALT
• Maddrey Discriminant function(DF) less than 30

Exclusion Criteria:

• Severe alcoholic hepatitis with cirrhosis or life expectancy less than 3 months
• Severe renal impairment (Glomerular filtration rate below 60 ml/min per 1.73m2)
• Hepatic disorders due to cardiac causes, inherited metabolic causes, hemochromatosis and Wilson's disease
• Participants with active viral hepatitis
• Under going active treatment for alcohol withdrawal syndrome(AWS) at the study entry
• Participants on hepatotoxic medications like antitubercular medication, antiviral medication, paracetamol etc.
• Pregnant, attempting to conceive, or lactating women
• Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.